Otsuka has claimed FDA approval for its IgA nephropathy (IgAN) therapy Voyxact, joining an increasingly crowded market and beating rival Vera Therapeutics to the punch. Anti-APRIL antibody Voyxact ...
The 247Sports Transfer Portal includes players who have either announced their intent to enter or have officially entered the NCAA Transfer Portal. Under the college transfer policy, when a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback